KKL 顾客使用本产品发表的 2 篇科研文献

Levofloxacin, a synthetic fluoroquinolone, is an antibacterial agent that inhibits the supercoiling activity of bacterial DNA gyrase, halting DNA replication. Target: Antibacterial Levofloxacin reduced bacterial load compared with placebo by 4.9-fold (95% confidence interval, 1.4-25.7; P=0.02) at day 7 but had no effect at any point on any marker of neutrophilic airway inflammation. In patients with a baseline bacterial load of more than 10(6) cfu/mL, levofloxacin treatment was associated with a 26.5% (95% confidence interval, 1.8%-51.3%; P=0.04) greater reduction in the percentage neutrophil count compared with placebo at day 7 . Levofloxacin was found to significantly improve the clinical and microbiological parameters in CP individuals . A 30-day course of levofloxacin does not significantly improve BK viral load reduction or allograft function when used in addition to overall reduction of immunosuppression .

• 2.

  请依序添加每种溶剂： 10% DMSO → 40% PEG300 → 5% Tween-80 →45% saline

  Solubility: ≥ 1 mg/mL (2.77 mM); Clear solution

  此⽅案可获得 ≥ 1 mg/mL (2.77 mM，饱和度未知) 的澄清溶液。

  以 1 mL ⼯作液为例，取 100 μL 10.0 mg/mL 的澄清 DMSO 储备液加到 400 μL PEG300 中，混合均匀；向上述体系中加⼊ 50 μ L Tween-80，混合均匀；然后继续加⼊ 450 μL ⽣理盐⽔定容⾄ 1 mL。

   
• 3.

  请依序添加每种溶剂： 10% DMSO → 90% (20% SBE-β-CD in saline)

  Solubility: ≥ 1 mg/mL (2.77 mM); Clear solution

  此⽅案可获得 ≥ 1 mg/mL (2.77 mM，饱和度未知) 的澄清溶液。

  以 1 mL ⼯作液为例，取 100 μL 10.0 mg/mL 的澄清 DMSO 储备液加到 900 μL 20% 的 SBE-β-CD ⽣理盐⽔⽔溶液中，混合均 匀。

• 4.

  请依序添加每种溶剂： 10% DMSO → 90% corn oil

  Solubility: ≥ 1 mg/mL (2.77 mM); Clear solution

  此⽅案可获得 ≥ 1 mg/mL (2.77 mM，饱和度未知) 的澄清溶液，此⽅案不适⽤于实验周期在半个⽉以上的实验。 以 1 mL ⼯作液为例，取 100 μL 10.0 mg/mL 的澄清 DMSO 储备液加到 900 μL ⽟⽶油中，混合均匀。

• •Clin Chem. 2019 Dec;65(12):1522-1531.
• •Antimicrob Agents Chemother. 2021 Feb 17;65(3):e01921-20.